Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model
Anesthesiology - United States
doi 10.1097/aln.0b013e31823de68d
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)